Tracey Liebman, MD, discusses the use of digital surveillance in melanoma.
Tracey Liebman, MD
Advertisement
Articles by Tracey Liebman, MD
Tracey Liebman, MD, discusses the toxicities associated with BRAF inhibitors in melanoma.
Advertisement
Latest Updated Articles
Dr. Liebman on Toxicities of BRAF Inhibitors in MelanomaPublished: January 31st 2020 | Updated:
Dr. Liebman on the Use of Digital Surveillance in MelanomaPublished: February 28th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
5